Hospira Cisplatin 1mg/mL Concentrate for Solution for Infusion 50mg/50mL vial

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

cisplatin, Quantity: 1 mg/mL

Disponible depuis:

Hospira Australia Pty Ltd

DCI (Dénomination commune internationale):

Cisplatin

forme pharmaceutique:

Injection, intravenous infusion

Composition:

Excipient Ingredients: mannitol; sodium chloride; water for injections; hydrochloric acid; sodium hydroxide

Mode d'administration:

Intravenous Infusion

Unités en paquet:

1x 50mL pack

classe:

Medicine Listed (Export Only)

Type d'ordonnance:

(S1) This Schedule is intentionally blank

indications thérapeutiques:

Cisplatin is used in the treatment of certain types of cancer, for example ovarian cancer, testicular cancer, bladder cancer and head and neck cancer. Cisplatin may be used in combination with other anti-cancer medicines.

Descriptif du produit:

Visual Identification: A clear, colourless to pale yellow solution, free from visible particulates.; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statut de autorisation:

Licence status A

Date de l'autorisation:

2009-02-11